Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 130 results for "sarabjit kour nangra"

Pharma gets a US shot in arm
Business Standard India

USFDA issues import alert on Sun Pharmaceuticals Karkhadi plan...

Views of Ms. Sarabjit Kour Nangra (VP - Research - Pharma, Angel Broking) USFDA issues import alert on Sun Pharmaceuticals Karkhadi plant:"The US Food and Drug Administration (FDA), issued an import alert to Sun Pharmaceuticals for all products ... Equity Bulls, 1 month ago
Pharma gets a US shot in arm Business Standard India, 2 weeks ago

2 images for "sarabjit kour nangra"

Business Standard India, 2 weeks ago, 4 months ago
Finance 24

Investors back Sun Pharma's Ranbaxy move (AFP)

On the surface, Sun Pharma's $US3.2 billion ($A3.42 billion) purchase of Indian generics rival Ranbaxy, which is in deep trouble with US regulators over safety lapses, may not look like a great deal. But Sun Pharmaceutical Industries' shares ...
 West Australian4 days ago Investors back Sun's Ranbaxy deal as well-calculated risky acquisition  Oman Tribune5 days ago Sun Pharma is able to revive Ranbaxy: investors  China Post5 days ago Investors hail Sun Pharma's Ranbaxy buy  Qatar Peninsula5 days ago
Business Standard India

Mid and small-cap stocks touch 15-monthclosing high

Stocks of the mid and small-sized companies have continued on their uptrend and have outperformed the benchmark indices in the last one-month period. Analysts said that relatively cheaper valuations along with a boost in sentiment have been pushing ...
 Business Standard India1 week ago Small, mid-cap stocks touch 15-month highs  Smart Investor1 week ago
Deccan Chronicle

Anlysts give thumbs-up to Sun Pharma-Ranbaxy deal

Sun Pharmaceutical Industries and Ranbaxy Laboratories have entered into definitive agreements pursuant to which Sun Pharma will acquire 100% of Ranbaxy in an all-stock transaction. Under these agreements, Ranbaxy shareholders will receive 0.8 share ...
 MyIris1 week ago Ranbaxy gives up, merges into Sun  Deccan Chronicle1 week ago A thumbs-up from analysts  Hindu Business Line1 week ago

Sun-Ranbaxy merger to push Dr Reddy's to second spot

Related to : Ranbaxy Laboratories Ltd,Sun Pharmaceuticals Industries Ltd Ranbaxy Laboratories Ltd BSE 07 Apr 14 | 03:59 PM 445.20 -14.35 (-3.12%) NSE 07 Apr 14 | 12:00 AM 445.75 -13.8 (-3%) The acquisition of Ranbaxy by Sun ...
 Smart Investor1 week ago Dr Reddys launches antibiotic drug in US  The Financial Chronicle1 month ago

Sun Pharma buys Ranbaxy for $3.2b, turns it Indian again

Soumonty Kanungo Mumbai Sun Pharmaceutical Industries, India’s largest drugmaker by market value, on Monday announced a deal to buy the Daiichi Sankyo-controlled Ranbaxy Laboratories in an all-stock deal worth $3.2 billion, thus creating the world’s fifth ...
 The Financial Chronicle1 week ago Bringing in the moolah  Express Pharma1 month ago Many experts skeptical of AstraZeneca's delisting plan's success  Topnews.in1 month ago Analysts not hopeful of AstraZeneca Pharma delisting sailing through  The Freepress Journal1 month ago

Daiichi Sankyo couldn't manage Ranbaxy; it is now in better hands: industry leaders

Sun Pharmaceuticals proposal to acquire Ranbaxy Laboratories is good for the ailing company, which now has a better chance to come out of the mess it is in, according to industry leaders and experts. VCCircle spoke to a cross section of third ...
 VC Circle1 week ago

Why Ranbaxy Buy Is Not The Biggest Risk For Sun's Shanghvi

Has the soft-spoken Dileep Shanghvi, the owner of Sun Pharmaceutical Industries, taken the biggest risk in his business life by acquiring the troubled Ranbaxy Laboratories in his quest to leapfrog into the top five generic companies in the world? ...
 Businessworld India1 week ago

Sun eclipses Ranbaxy on Street; experts' take on $3.2 bn deal

NEW DELHI: Shares of Sun Pharma, which have largely remained flat so far in 2014, may well see some upside after announcing that it would acquire 100 per cent of Ranbaxy in an all-stock transaction. Shares of Sun Pharma closed the day on the Bombay ...
 Economic Times1 week ago Sun Pharma can double investor wealth in 2 years, says expert  Economic Times1 week ago
International Business Times UK

Lupin buys Mexico's Grin in bid to move beyond alliance

Mumbai Pharma major Lupin has acquired Mexico-based Laboratorios Grin for an undisclosed amount as part of its strategy to grow inorganically in Japan, Brazil and Mexico. Vinod Dhawan, Lupin's president, business development, said the Mexico ...
 Financial Chronicle3 weeks ago Indian Drugmaker Lupin Buys Mexico's Laboratorios Grin  International Business Times UK3 weeks ago Grin acquisition may provide lot of synergies for Lupin: Angel Broking  Myiris3 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - sarabjit kour nangra
Get updated on latest news & your favorite topics right in your inbox!
More     Less